NASDAQ: DMAA
Drugs Made In America Acquisition Corp Stock Ownership - Who owns Drugs Made In America Acquisition?

Insider buying vs selling

Have Drugs Made In America Acquisition Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DMAA insiders and whales buy or sell their stock.

DMAA Shareholders

What type of owners hold Drugs Made In America Acquisition Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lynn Stockwell34.38%8,347,560$90.49MInsider
Drugs Made In America Acquisition LLC17.25%4,188,780$45.41MInsider
Catherine Do0.41%100,000$1.08MInsider
Sridhar G. Prasad0.41%100,000$1.08MInsider
Myron W. Shulgan0.41%100,000$1.08MInsider
Glenn C. Worman0.41%100,000$1.08MInsider
Karpus0.01%2,508$27.19kInstitution
Karpus Management Inc0.01%2,507$27.18kInstitution
Mizusa0.01%2,070$22.44kInstitution
Mizuho Securities Usa LLC 10.01%2,069$22.43kInstitution

1 of 3

DMAA vs Shell Company Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMAA0.05%53.29%
NTWO0.07%2.01%
OACC0.07%2.38%
PNAQ.U0.00%12.44%Net BuyingNet Buying
HVII0.07%5.76%

Drugs Made In America Acquisition Stock Ownership FAQ

Who owns Drugs Made In America Acquisition?

Drugs Made In America Acquisition (NASDAQ: DMAA) is owned by 0.05% institutional shareholders, 53.29% Drugs Made In America Acquisition insiders, and 46.66% retail investors. Lynn Stockwell is the largest individual Drugs Made In America Acquisition shareholder, owning 8.35M shares representing 34.38% of the company. Lynn Stockwell's Drugs Made In America Acquisition shares are currently valued at $90.49M.

If you're new to stock investing, here's how to buy Drugs Made In America Acquisition stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.